| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | SYMPHONY BIOSCIENCES INC | 570 WESTWOOD PLZ | LOS ANGELES | CA | 90095-8352 | LOS ANGELES | USA | R44CA281563 | Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer | 000 | 2 | NIH | 11/4/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $992,724 ) |
| | 2024 | 2024 | SYMPHONY BIOSCIENCES INC | 570 WESTWOOD PLZ | LOS ANGELES | CA | 90095-8352 | LOS ANGELES | USA | R44CA281563 | Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer | 000 | 2 | NIH | 9/17/2024 | $992,724 |
|
| Issue Date FY: 2023 ( Subtotal = $399,586 ) |
| | 2023 | 2023 | SYMPHONY BIOSCIENCES INC | 570 WESTWOOD PLZ | LOS ANGELES | CA | 90095-8352 | LOS ANGELES | USA | R44CA281563 | Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer | 000 | 1 | NIH | 4/19/2023 | $399,586 |
|
|
